Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangping Xia

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Nature Metabolism|September 4, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapyChenran Wang, Maohua Huang, Yuning Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2022
Smad4 Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer-Autonomous DNA-Sensing Signaling AxisWenjing Xiong, Wenzhuo He, Tiantian Wang, et al.
The Journal of Clinical Investigation|August 11, 2022
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis modelsMing Qi, Shuran Fan, Maohua Huang, et al.
Signal Transduction and Targeted Therapy|September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trialBo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Nature Metabolism|September 4, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapyChenran Wang, Maohua Huang, Yuning Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2022
Smad4 Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer-Autonomous DNA-Sensing Signaling AxisWenjing Xiong, Wenzhuo He, Tiantian Wang, et al.
The Journal of Clinical Investigation|August 11, 2022
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis modelsMing Qi, Shuran Fan, Maohua Huang, et al.
Signal Transduction and Targeted Therapy|September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trialBo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Pageof 9